Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Nita Williams"'
Autor:
Michael Ozga, Qiuhong Zhao, Don Benson Jr., Patrick Elder, Nita Williams, Naresh Bumma, Ashley Rosko, Maria Chaudhry, Abdullah Khan, Srinivas Devarakonda, Rami Kahwash, Ajay Vallakati, Courtney Campbell, Samir V. Parikh, Salem Almaani, Jason Prosek, Jordan Bittengle, Katherine Pfund, Samantha LoRusso, Miriam Freimer, Elyse Redder, Yvonne Efebera, Nidhi Sharma
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 965-973 (2021)
Abstract Background Systemic light chain (AL) amyloidosis is a clonal plasma‐cell neoplasm that carries a poor prognosis. Although AL amyloidosis and Multiple Myeloma (MM) can co‐exist and share various cytogenetic chromosomal abnormalities, litt
Externí odkaz:
https://doaj.org/article/838fc5affe834c6d83e8b15aaa975cc8
Autor:
Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang, Mat Makowski, Elshafa Hassan Ahmed, Sarah Schlotter, Rebecca Pearson, Rhonda Kitzler, Anna Mozhenkova, Jennifer Le-Rademacher, Richard F. Little, Gorgun Akpek, Ernesto Ayala, Steven M. Devine, Lawrence D. Kaplan, Ariela Noy, Uday R. Popat, Jack W. Hsu, Lawrence E. Morris, Adam M. Mendizabal, Amrita Krishnan, William Wachsman, Nita Williams, Nidhi Sharma, Craig C. Hofmeister, Stephen J. Forman, Willis H. Navarro, Joseph C. Alvarnas, Richard F. Ambinder, Gerard Lozanski, Robert A. Baiocchi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
We report a first in-depth comparison of immune reconstitution in patients with HIV-related lymphoma following autologous hematopoietic cell transplant (AHCT) recipients (n=37, lymphoma, BEAM conditioning), HIV(-) AHCT recipients (n=30, myeloma, melp
Externí odkaz:
https://doaj.org/article/11e102a0fff440d19a1c2e8eecf7cba8
Autor:
Francesca Cottini, Ying Huang, Nita Williams, Naresh Bumma, Abdullah M. Khan, Maria Chaudhry, Srinivas Devarakonda, Yvonne A. Efebera, Don M. Benson, Ashley E. Rosko
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Multiple myeloma (MM) is an incurable disease with a limited life expectancy of five years from diagnosis. Uncontrolled disease or infections are the main causes of mortality. Daratumumab, a monoclonal antibody against CD38, is approved to treat pati
Externí odkaz:
https://doaj.org/article/bd3cf06e2e61452e9e916a5d0e927d54
Autor:
Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang, Mat Makowski, Elshafa Ahmed, Rebecca Pearson, Rhonda Kitzler, Jennifer G. Le-Rademacher, Richard F Little, Görgün Akpek, Ernesto Ayala, Steven M. Devine, Lawrence D. Kaplan, Ariela Noy, Uday R. Popat, Jack W. Hsu, Lawrence E Morris, Adam Mendizabal, William Wachsman, Nita Williams, Nidhi Sharma, Craig C Hofmeister, Stephen J. Forman, Willis H. Navarro, Joseph C. Alvarnas, Richard F. Ambinder, Carlos Malvestutto, Hannah Choe, Gregory Behbehani, Gerard Lozanski, Bradley Blaser, Robert Baiocchi
Publikováno v:
Transplantation and Cellular Therapy. 29:S67-S68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9aceb1e138266ee68b577bf5a68c160
https://doi.org/10.1016/s2666-6367(23)00149-5
https://doi.org/10.1016/s2666-6367(23)00149-5
Autor:
Samantha LoRusso, Qiuhong Zhao, Jason Prosek, Katherine Pfund, Srinivas Devarakonda, Ashley E. Rosko, Patrick Elder, Elyse Redder, Ajay Vallakati, Jordan Bittengle, Yvonne A. Efebera, Courtney M. Campbell, Maria Chaudhry, Salem Almaani, Nidhi Sharma, Samir V. Parikh, Naresh Bumma, Don M. Benson, Abdullah Khan, Rami Kahwash, Nita Williams, Miriam Freimer, Michael Ozga
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 3, Pp 965-973 (2021)
Cancer Medicine, Vol 10, Iss 3, Pp 965-973 (2021)
Background Systemic light chain (AL) amyloidosis is a clonal plasma‐cell neoplasm that carries a poor prognosis. Although AL amyloidosis and Multiple Myeloma (MM) can co‐exist and share various cytogenetic chromosomal abnormalities, little is kno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a708880211d48cb697907f21da4ca2
http://europepmc.org/articles/PMC7897960
http://europepmc.org/articles/PMC7897960
Autor:
Douglas W. Sborov, Yvonne A. Efebera, Qiuhong Zhao, Craig C. Hofmeister, Don M. Benson, Srinivas Devarakonda, Nidhi Sharma, David Chen, Naresh Bumma, Abdullah Khan, Maria Chaudhry, Nita Williams, Ashley E. Rosko
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:44-49
Post-autologous stem cell transplantation (ASCT) maintenance therapy with lenalidomide is standard of care for patients with multiple myeloma (MM). Effective and tolerable drug combinations may further enhance the clinical response post-ASCT. Vorinos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69332cddc91060755161ccf9734d612
https://doi.org/10.1016/j.bbmt.2019.09.005
https://doi.org/10.1016/j.bbmt.2019.09.005
Autor:
R Reinbolt, Maryam B. Lustberg, S Asad, Elizabeth Adams, Robert Wesolowski, Yu Jing Jan Heng, A Damicis, Nita Williams, William Nock, AH Eliassen, Yiqing Zhang, Susan E. Hankinson, B Ramaswamy, Sagar Sardesai, Jasneet Singh, Anne M. Noonan, Daniel G. Stover, Jeffrey VanDeusen, Rulla M. Tamimi, Kevin H. Kensler
Publikováno v:
Cancer Research. 79:P1-09
Background: Our understanding of mediators of immune infiltration in breast cancer and normal breast tissue remains limited. We hypothesize that patient factors known to be associated with inflammation and immune subsets, including body mass index, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::137451db89092515dfa56871a1ebe625
https://doi.org/10.1158/1538-7445.sabcs18-p1-09-01
https://doi.org/10.1158/1538-7445.sabcs18-p1-09-01
Autor:
Julie A. Stephens, Sagar Sardesai, Robert Wesolowski, Marilly Palettas, B Ramaswamy, Nita Williams, R Reinbolt, Maryam B. Lustberg, Daniel G. Stover, Jeffrey VanDeusen, Joseph Liu
Publikováno v:
Cancer Research. 79:P4-16
Background: Trastuzumab (T) induced cardiomyopathy remains a significant limitation to adjuvant HER2 directed therapy. Recent studies have aimed to reduce cardiotoxicity through combination with non-anthracycline (non-A) chemotherapy or shorter treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::938de81ca24c0371826b1331f70d39bb
https://doi.org/10.1158/1538-7445.sabcs18-p4-16-03
https://doi.org/10.1158/1538-7445.sabcs18-p4-16-03
Autor:
Maria Chaudhry, Yvonne A. Efebera, Ying Huang, Ashley E. Rosko, Nita Williams, Don M. Benson, Naresh Bumma, Abdullah Khan, Francesca Cottini, Srinivas Devarakonda
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
Multiple myeloma (MM) is an incurable disease with a limited life expectancy of five years from diagnosis. Uncontrolled disease or infections are the main causes of mortality. Daratumumab, a monoclonal antibody against CD38, is approved to treat pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c62355ba231ebbbd7c2ae316f1666d0
https://pubmed.ncbi.nlm.nih.gov/33659205
https://pubmed.ncbi.nlm.nih.gov/33659205
Autor:
Nidhi Sharma, Don M. Benson, Yvonne A. Efebera, Allyson Waller, Craig C. Hofmeister, Ying Huang, Hallie Barr, Nita Williams, Jessica Dempsey, Ashley E. Rosko
Publikováno v:
Leukemia. 32:2495-2518
Background: Daratumumab, an anti-CD38 monoclonal antibody, was first approved for the treatment of relapsed and refractory multiple myeloma (MM) in December of 2015. The approved initial infusion lasts at least 6.5 hours, second infusion for 4.5 hour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c052abbb8a354736684876253681428f
https://doi.org/10.1038/s41375-018-0120-2
https://doi.org/10.1038/s41375-018-0120-2